According to the news on June 29 on the WeChat official account of "Beijing Release", Yin Yong, the mayor of Beijing, met with Ou Bingde, executive vice president of Sanofi Group and head of the global manufacturing and supply business on the afternoon of June 28.
Yin Yong said that as the capital, Beijing has gathered rich resources in medical and health technology, education, and talent, and has a good foundation for the development of the medical and health industry and an innovative ecosystem. In recent years, relying on the construction of the "two districts", it has steadily promoted high-level external opening with a focus on institutional opening up, continuously created a market-oriented, legal, convenient, and internationalized first-class business environment, vigorously carried out policy pilot reforms in the field of medical and health, and the development momentum of the medical and health industry is strong. Sanofi is a globally renowned pharmaceutical company that hopes to fully utilize Beijing's resource advantages, further increase research and development investment and industrial chain supply chain layout in Beijing, deepen industry university research cooperation with enterprises and institutions in Beijing, and jointly promote the high-quality development of the pharmaceutical and health industry. Beijing will continue to improve the "service package" and "service manager" systems, and make every effort to provide good services for the development and investment of various enterprises in Beijing.
Ou Bingde highly appreciates the business environment and service level to enterprises in Beijing, and expresses that Sanofi has witnessed and participated in the process of China's reform and opening up and the construction and development of Beijing. It is willing to continue to deeply cultivate the Chinese market, increase research and development investment and production layout in Beijing, and benefit more patients.
The Secretary General of the Municipal Government, Zeng Jin, attended the meeting.